Perspectives of multi-OMICS analysis from blood, saliva and tumor tissue in patients with oral cavity carcinomas with regard to diagnostics, therapy and recurrence detection.
- Conditions
- C06Malignant neoplasm of lipMalignant neoplasm of base of tongueMalignant neoplasm of other and unspecified parts of tongueC00C01C02C03C04C05
- Registration Number
- DRKS00030492
- Lead Sponsor
- Bundeswehrkrankenhaus Ulm
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Newly diagnosed tumors of the oral cavity
- Indication for surgical therapy
Exclusion Criteria
- Simultaneous malignancies
- Patient refusal to participate in the study
- No indication for surgical therapy
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method OMICS signatures 3,6 and 12 month after operation
- Secondary Outcome Measures
Name Time Method Survival after 5 years